Teladoc Health CFO Mala Murthy resigns; preliminary Q3 revenue $626.4M, adj EBITDA $69.9M

Teladoc Health, Inc.

CFO Mala Murthy to resign effective Nov 21, 2025; interim finance leaders reporting to CEO.
Preliminary Q3 2025 consolidated revenue $626.4M, adjusted EBITDA $69.9M (unaudited).
Full-year 2025 consolidated revenue and adjusted EBITDA outlook reaffirmed (from July 29).
CFO search initiated; Murthy will present on Q3 earnings call Oct 29.
No GAAP EPS or segment details provided; full results to be released Oct 29.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.